| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c396fbadccfdb2a044f8f92cd2c6e74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8edbabf3f9cf7d81638785da0d9fd748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01b1347b7c9afdcc6dea6eee5e49b984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fd7186a6e7203ef05394776a5537c79 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
| filingDate |
1997-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b34f642c7904791ae9bdeb698f94057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee6c75f8d8d09a2e0b622c2d1c3da540
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3af12442fbb2004445dc47caa68fc420
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b63fe163a80d10563ec59f92a0397ba7 |
| publicationDate |
2004-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2262637-C |
| titleOfInvention |
Use of hyaluronidase |
| abstract |
The use of hyaluronidase in the manufacturing of a drug for the treatment of conditions of interstitial edema in connection with organ grafting associated with an increased local content of hyaluronan in the connective tissue of a mammal. The drug comprises hyaluronidase in an amount giving a daily dosage of from 1 to 100,000 IU/kg body weight wh en given locally or systemically to a mammal. A method of treating conditions of interstitial edema in connection with organ grafti ng associated with an increased local synthesis of hyaluronan by systemic or local treatment with a pharmaceutical comprising hyaluronidase.< /SDOAB> |
| priorityDate |
1996-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |